BRPI0822713A2 - Método de produção de toxina clostridium botulinum - Google Patents

Método de produção de toxina clostridium botulinum

Info

Publication number
BRPI0822713A2
BRPI0822713A2 BRPI0822713-6A2A BRPI0822713A BRPI0822713A2 BR PI0822713 A2 BRPI0822713 A2 BR PI0822713A2 BR PI0822713 A BRPI0822713 A BR PI0822713A BR PI0822713 A2 BRPI0822713 A2 BR PI0822713A2
Authority
BR
Brazil
Prior art keywords
production method
clostridium botulinum
toxin clostridium
toxin
botulinum
Prior art date
Application number
BRPI0822713-6A2A
Other languages
English (en)
Inventor
Hyun-Ho Jung
Gi-Hyeok Yang
Hack-Woo Kim
Byung-Kook Lee
Young-Suk Yoon
Hyung-Pyo Hong
Original Assignee
Medy Tox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medy Tox Inc filed Critical Medy Tox Inc
Publication of BRPI0822713A2 publication Critical patent/BRPI0822713A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24069Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
BRPI0822713-6A2A 2008-05-19 2008-07-02 Método de produção de toxina clostridium botulinum BRPI0822713A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080046152A KR20090120222A (ko) 2008-05-19 2008-05-19 식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여클로스트리디움 보툴리눔 독소를 생산하는 방법
PCT/KR2008/003897 WO2009142352A1 (en) 2008-05-19 2008-07-02 Method of producing clostridium botulinum toxin using media containing plant-derived components and flexible closed container

Publications (1)

Publication Number Publication Date
BRPI0822713A2 true BRPI0822713A2 (pt) 2014-11-18

Family

ID=41340273

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0822713-6A2A BRPI0822713A2 (pt) 2008-05-19 2008-07-02 Método de produção de toxina clostridium botulinum

Country Status (7)

Country Link
US (1) US8993268B2 (pt)
EP (2) EP2276851A4 (pt)
JP (1) JP2011520463A (pt)
KR (1) KR20090120222A (pt)
CN (1) CN102089438A (pt)
BR (1) BRPI0822713A2 (pt)
WO (1) WO2009142352A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617568B2 (en) * 2007-07-10 2013-12-31 Medy-Tox, Inc. Pharmaceutical liquid composition of botulinum toxin with improved stability
HUE037595T2 (hu) 2008-12-31 2018-09-28 Revance Therapeutics Inc Injektálható botulinum toxin készítmények
KR101134146B1 (ko) * 2010-05-31 2012-04-19 메덱스젠 주식회사 국소 근마비 효과를 갖는 비확산형 보툴리눔 독소와 그의 정제방법
US9480731B2 (en) * 2013-12-12 2016-11-01 Medy-Tox, Inc. Long lasting effect of new botulinum toxin formulations
KR101729251B1 (ko) * 2015-04-28 2017-04-21 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101723168B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101723167B1 (ko) 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101775682B1 (ko) * 2015-11-30 2017-09-06 주식회사 대웅 보툴리눔 독소의 제조방법
BR112019004929A2 (pt) 2016-09-13 2019-06-04 Allergan Inc composições de toxina clostridial não proteíca
KR102209159B1 (ko) * 2019-03-29 2021-01-29 (주)제테마 독소의 제조방법
KR102197224B1 (ko) * 2019-03-29 2020-12-31 (주)제테마 배지 조성물
KR102516204B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 정제방법
KR102516203B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 제조방법
US10851363B1 (en) * 2019-05-22 2020-12-01 Boke Zhang Multilayer nano-cell containing biomolecules
KR102287437B1 (ko) * 2019-08-14 2021-08-09 주식회사 프로톡스 보툴리눔 독소의 제조방법
EP4013852A1 (en) * 2019-08-16 2022-06-22 Janssen Biotech, Inc. Optimized culture media for clostridia bacteria
CN113430241A (zh) * 2021-06-17 2021-09-24 杨凌质量技术检测检验所 一种食品病菌检测试剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005222A1 (en) * 1994-08-08 1996-02-22 Wisconsin Alumni Research Foundation Purification and pharmaceutical compositions containing type g botulinum neurotoxin
US5756468A (en) * 1994-10-13 1998-05-26 Wisconsin Alumni Research Foundation Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
US6190913B1 (en) * 1997-08-12 2001-02-20 Vijay Singh Method for culturing cells using wave-induced agitation
CH697035A5 (de) * 1999-05-04 2008-03-31 Marcel Roell Bioreaktor.
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US6544788B2 (en) * 2001-02-15 2003-04-08 Vijay Singh Disposable perfusion bioreactor for cell culture
US6673598B1 (en) * 2002-10-29 2004-01-06 Synthecon, Inc. Disposable culture bag
US7160699B2 (en) * 2003-09-25 2007-01-09 Allergan, Inc. Media for clostridium bacterium and processes for obtaining a clostridial toxin
US7148041B2 (en) * 2003-09-25 2006-12-12 Allergan, Inc. Animal product free media and processes for obtaining a botulinum toxin
KR20070115580A (ko) 2005-03-03 2007-12-06 알러간, 인코포레이티드 클로스트리디움 박테리아를 위한 배지 및 클로스트리디움계독소를 얻기 위한 프로세스

Also Published As

Publication number Publication date
CN102089438A (zh) 2011-06-08
US8993268B2 (en) 2015-03-31
WO2009142352A1 (en) 2009-11-26
EP2276851A1 (en) 2011-01-26
KR20090120222A (ko) 2009-11-24
EP2733216A1 (en) 2014-05-21
JP2011520463A (ja) 2011-07-21
EP2276851A4 (en) 2013-05-08
EP2733216B1 (en) 2018-06-13
US20110091937A1 (en) 2011-04-21

Similar Documents

Publication Publication Date Title
BRPI0822713A2 (pt) Método de produção de toxina clostridium botulinum
IL281675A (en) Injectable botulinum toxin preparations
HK1247629A1 (zh) 用於獲得肉毒桿菌神經毒素的方法和系統
BRPI0916499A2 (pt) método de produção de biomassa
HK1151298A1 (en) Immuno-based botulinum toxin serotype ctivity ssays
BRPI0922208A2 (pt) método de mineração de minerio.
EP2419128A4 (en) MANIPULATED BOTULINUM NEUROTOXIN
DK2650003T3 (da) Nedbrydelige clostridiumtoksiner
BRPI0920540A2 (pt) método de produção de álcool
BRPI1009361A2 (pt) produção de produtos finais fermentativos de clostridium sp.
EP2313434A4 (en) NEUTRALIZING ANTIBODIES OF BOTULINIC NEUROTOXINS
BRPI0913920A2 (pt) método de produção de neopentil glicol
BRPI0918857A2 (pt) método de produção de poliamida
BRPI0922490A2 (pt) Método para produção de beta-santaleno
BRPI0914408A2 (pt) máquina e método de operação de máquina
GB0800927D0 (en) Botulinum neurotoxin vaccine
BRPI0923001A2 (pt) método de produção de lipossomas pequenos
BRPI0823108A2 (pt) Metodo de operacao de extrusor
BRPI0910115A2 (pt) Método de produção de óxido de propileno
BRPI1011014A2 (pt) método de produção.
BR112012004367A2 (pt) método de detecção de adulteração.
BRPI0914877A2 (pt) método de purificação de eritropoietina
DK2260130T3 (da) Fremgangsmåde til øget enzymaktivitet
BRPI1009809A2 (pt) método de vedação por compressão full bore.
BRPI0815419A2 (pt) Método de produção

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.